Fulgent Genetics completes $56.9 million acquisition of two labs

March 17, 2026 4:31 PM

Fulgent Genetics Inc. (NASDAQ: FLGT) completed its acquisition of Bako Diagnostics and StrataDx for approximately $56.9 million in cash, the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found